The Impact of Endocrine Disruptors on Endocrine Targets

Abstract

Endocrine disruption represents one of the most controversial environmental issues of our époque. So far, many substances, both natural and artificial, have been recognized to interfere with endocrine signaling pathways. In intact laboratory animals, this interaction has been documented to generate adverse health outcomes by impairing normal functions. With regard to humans, evidence is limited and inconsistent to clearly establish a causal inference, however, accumulating data incriminate endocrine disrupting chemicals to reproductive disorders and disturbed thyroid homeostasis. Recently, as a result of animal models and preliminary human studies, a new area of interest has arisen concerning the implication of endocrine disruptors in the etiology of obesity and diabetes, the two major, life-threatening, epidemics of modern world. This article reviews the evidence linking endocrine disrupting chemicals to a broad spectrum of clinical perturbations from reproduction and thyroid to metabolic regulation.

endocrine disruptors - male reproduction - female reproduction - thyroid - obesity - diabetes

References

• 1 EPA. U.S.. Special report on Environmental Endocrine Disruption: An Effects Assessment and Analysis. Office of Research and Development,1997,EPA/630/R-96/012, Washington D.C.;
• 2 Tabb MM, Blumberg B. New modes of action for endocrine-disrupting chemicals.  Mol Endocrinol. 2006;  20 475-482
• 3 Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, Zoeller RT, Gore AC. Endocrine-disrupting chemicals: An endocrine society scientific statement.  Endocr Rev. 2009;  30 293-342
• 4 Singer PL. Occupational oligospermia.  JAMA. 1949;  140 1249
• 5 Lancranjan I, Popescu HI, Gavanescu O, Klepsch I, Serbanescu M. Reproductive ability of workmen occupationally exposed to lead.  Arch Environ Health. 1975;  30 396-401
• 6 Toppari J, Larsen JC, Christiansen P, Giwercman A, Grandjean P, Guillette Jr. LJ, Jégou B, Jensen TK, Jouannet P, Keiding N, Leffers H, McLachlan JA, Meyer O, Müller J, Rajpert-De Meyts E, Scheike T, Sharpe R, Sumpter J, Skakkebaek NE. Male reproductive health and environmental xenoestrogens.  Environ Health Perspect. 1996;  104 741-803
• 7 Sharpe RM, Skakkebæk NE. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract?.  Lancet. 1993;  341 1392-1395
• 8 Skakkebæk NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects.  Hum Reprod Update. 2001;  16 972-978
• 9 Sharpe RM, Skakkebæk NE. Male reproductive disorders and the role of endocrine disruption: advances in understanding and identification of areas for future research.  Pure Appl Chem. 2003;  75 2023-2038
• 10 Sharpe RM, Skakkebæk NE. Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects.  Fertil Steril. 2008;  89 33-38
• 11 Hauser R, Meeker JD, Duty S, Silva MJ, Calafat AM. Altered semen quality in relation to urinary concentrations of phthalate monoester and oxidative metabolites.  Epidemiology. 2006;  17 682-691
• 12 De Jager C, Farias P, Barraza-Villarreal A, Avila MH, Ayotte P, Dewailly E, Dombrowski C, Rousseau F, Sanchez VD, Bailey JL. Reduced seminal parameters associated with environmental DDT exposure and p,p′-DDE concentrations in men in Chiapas, Mexico: a cross-sectional study.  J Androl. 2006;  27 16-27
• 13 Meeker JD, Rossano MG, Protas B, Diamond MP, Puscheck E, Daly D, Paneth N, Wirth JJ. Cadmium, lead, and other metals in relation to semen quality: Human evidence for molybdenum as a male reproductive toxicant.  Environ Health Perspect. 2008;  116 1473-1479
• 14 Dallinga JW, Moonen EJ, Dumoulin JC, Evers JL, Geraedts JP, Kleinjans JC. Decreased human semen quality and organochlorine compounds in blood.  Hum Reprod. 2002;  17 1973-1979
• 15 Hauser R, Chen Z, Pothier L, Ryan L, Altshul L. The relationship between human semen parameters and environmental exposure to polychlorinated biphenyls and p,p′-DDE.  Environ Health Perspect. 2003;  111 1505-1511
• 16 Mocarelli P, Gerthoux PM, Patterson D-G, Milani S, Limonta G, Bertona M, Signorini S, Tramacere P, Colombo L, Crespi C, Brambilla P, Sarto C, Carreri V, Sampson EJ, Turner WE, Needham LL. Dioxin exposure, from infancy through puberty, produces endocrine disruption and affects human semen quality.  Environ Health Perspect. 2008;  116 70-77
• 17 Newbold R. Cellular and molecular effects of developmental exposure to diethylstibestrol: Implications for other environmental estrogens.  Environ Health Perspect. 1995;  103 83-87
• 18 Maffini MV, Rubin BS, Sonnenschein C, Soto AM. Endocrine disruptors and reproductive health: The case of bisphenol-A.  Mol Cell Endocrinol. 2006;  254–255 179-186
• 19 Fernandez MF, Olmos B, Granada A, López-Espinosa MJ, Molina-Molina JM, Fernandez JM, Cruz M, Olea-Serrano F, Olea N. Human exposure to endocrine-disrupting chemicals and prenatal risk factors for cryptorchidism and hypospadias: A nested case-control study.  Environ Health Perspect. 2007;  115 8-14
• 20 Brucker-Davis F, Wagner-Mahler K, Delattre I, Ducot B, Ferrari P, Bongain A, Kurzenne JY, Mas JC, Fénichel P. Cryptorchidism study group from Nice area. Cryptorchidism at birth in Nice area (France) is associated with higher prenatal exposure to PCBs and DDE, as assessed by colostrum concentrations.  Hum Reprod. 2008;  23 1708-1718
• 21 Gray Jr LE, Ostby J, Furr J, Price M, Veeramachaneni DN, Parks L. Perinatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat.  Toxicol Sci. 2000;  58 350-365
• 22 Gray Jr. LE, Ostby J, Monosson E, Kelce WR. Environmental antiandrogens: low doses of the fungicide vinclozolin alter sexual differentiation of the male rat.  Toxicol Ind Health. 1999;  15 48-64
• 23 Ostby J, Kelce WR, Lambright C, Wolf CJ, Mann P, Gray LE. The fungicide procymidone alters sexual differentiation in the male rat by acting as an androgen-receptor antagonist in vivo and in vitro.  Toxicol Ind Health. 1999;  15 80-93
• 24 Pierik FH, Burdork A, Deddens JA, Juttman RE, Weber RF. Maternal and paternal risk factors for cryptorchidism and hypospadias: A case-control study in newborn boys.  Environ Health Perspect. 2004;  112 1570-1576
• 25 Schrager S, Potter BE. Diethylstilbestrol exposure.  Am Fam Physician. 2004;  69 2395-2400
• 26 Hardell L, van Bavel B, Lindström G, Carlberg M, Dreifaldt AC, Wijkström H, Starkhammar H, Eriksson M, Hallquist A, Kolmert T. Increased concentrations of polychlorinated biphenyls, hexachlorobenzene, and chlordanes in mothers of men with testicular cancer.  Environ Health Perspect. 2003;  111 930-934
• 27 Prins GS. Endocrine disruptors and prostate cancer risk.  Endocr Relat Cancer. 2008;  15 649-656
• 28 Ho SM, Tang WY, Belmonte de Frausto J, Prins GS. Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodisesterase type 4 variant 4.  Cancer Res. 2006;  66 5624-5632
• 29 Benbrahim-Tallaa L, Liu J, Webber MM, Waalkes MP. Estrogen signaling and disruption of androgen metabolism in acquired androgen-independence during cadmium carcinogenesis in human prostate epithelial cells.  Prostate. 2007;  67 135-145
• 30 Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina.  N Engl J Med. 1971;  284 878-881
• 31 Kaufman RH, Adam E, Hatch EE, Noller K, Herbst AL, Palmer JR, Hoover RN. Continued follow-up of pregnancy outcomes in diethylstilbestrol-exposed offspring.  Obstet Gynecol. 2000;  96 483-489
• 32 Block K, Kardana A, Igarashi P, Taylor HS. In utero diethylstilbestrol (DES) exposure alters Hox gene expression in the developing müllerian system.  FASEB J. 2000;  14 1101-1108
• 33 Newbold RR, Hanson RB, Jefferson WN, Bullock BC, Haseman J, McLachlan JA. Increased tumors but uncompromised fertility in the female descendants of mice exposed developmentally to diethylstilbestrol.  Carcinogenesis. 1998;  19 1655-1663
• 34 Titus-Ernstoff L, Troisi R, Hatch EE, Wise LA, Palmer J, Hyer M, Kaufman R, Adam E, Strohsnitter W, Noller K, Herbst AL, Gibson-Chambers J, Hartge P, Hoover RN. Menstrual and reproductive characteristics of women whose mothers were exposed in utero to diethylstilbestrol (DES).  Int J Epidemiol. 2006;  35 862-868
• 35 Euling SY, Herman-Giddens ME, Lee PA, Selevan SG, Juul A, Sorensen TI, Dunkel L, Himes JH, Teilmann G, Swan SH. Examination of US puberty-timing data from 1940 to 1994 for secular trends: panel findings.  Pediatrics. 2008;  121 172-191
• 36 Buck Louis GM, Gray Jr LE, Marcus M, Ojeda SR, Pescovitz OH, Witchel SF, Sippell W, Abbott DH, Soto A, Tyl RW, Bourguignon JP, Skakkebaek NE, Swan SH, Golub MS, Wabitsch M, Toppari J, Euling SY. Environmental factors and puberty timing: expert panel research needs.  Pediatrics. 2008;  121 192-207
• 37 Howdeshell KL, Hotchkiss AK, Thayer KA, Vandenbergh JG, vom Saal FS. Environmental toxins: Exposure to bisphenol A advances puberty.  Nature. 1999;  401 763-764
• 38 Den Hond E, Schoeters G. Endocrine disrupters and human puberty.  Int J Androl. 2006;  29 264-271
• 39 Mendola P, Messer L-C, Rappazzo K. Science linking environmental contaminant exposures with fertility and reproductive health impacts in the adult female.  Fertil Steril. 2008;  89 81-94
• 40 Colon I, Caro D, Bourdony CJ, Rosario O. Identification of phthalate esters in the serum of young Puerto Rican girls with premature breast development.  Environ Health Perspect. 2000;  108 895-900
• 41 Krstevska-Konstantinove M, Charlier C, Craen M, Du Caju M, Heinrichs C, Beaufort C, Plomteux G, Bourguignon JP. Sexual precocity after immigration from developing countries to Belgium: Evidence of previous exposure to organochlorine pesticides.  Hum Reprod. 2001;  16 1020-1026
• 42 Greenlee AR, Arbuckle TE, Chyou P. Risk factors for female infertility in an agricultural region.  Epidemiology. 2003;  14 429-436
• 43 Caserta D, Maranghi L, Mantovani A, Marci R, Maranghi F, Moscarini M. Impact of endocrine disruptor chemicals in gynaecology.  Hum Reprod Update. 2008;  14 59-72
• 44 Hruska KS, Furth PA, Seifer DB, Sharara FI, Flaws JA. Environmental factors in infertility.  Clin Obstet Gynecol. 2000;  43 821-829
• 45 Sharara FI, Seifer DB, Flaws JA. Environmental toxicants and female reproduction.  Fertil Steril. 1998;  70 613-622
• 46 Younglai EV, Foster WG, Hughes EG, Trim K, Jarrell JF. Levels of environmental contaminants in human follicular fluid, serum, and seminal plasma of couples undergoing in vitro fertilization.  Arch Environ Contam Toxicol. 2002;  43 121-126
• 47 Uzumcu M, Zachowa R. Developmental exposure to environmental endocrine disruptors:Consequences within the ovary and on female reproductive function.  Reprod Toxicol. 2007;  23 337-352
• 48 Mlynarcikova A, Fickova M, Scsukova S. Ovarian intrafollicular processes as a target for cigarette smoke components and selected environmental reproductive disruptors.  Endocr Regul. 2005;  39 21-32
• 49 Diamanti-Kandarakis E, Piperi C, Korkolopoulou P, Kandaraki E, Levidou G, Papalois Á, Patsouris E, Papavassiliou AG. Accumulation of dietary glycotoxins in the reproductive system of normal female rats.  J Mol Med. 2007;  85 1413-1420
• 50 Diamanti-Kandarakis E, Piperi C, Patsouris E, Korkolopoulou P, Panidis D, Pawelczyk L, Papavassiliou AG, Duleba AJ. Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries.  Histochem Cell Biol. 2007;  127 581-589
• 51 Tatone C, Amicarelli F, Carbone MC, Monteleone P, Caserta D, Marci R, Artini PG, Piomboni P, Focarelli R. Cellular and molecular aspects of ovarian follicle ageing.  Hum Reprod Update. 2008;  14 131-142
• 52 Davis BJ, Marnopot RR, Heindel JJ. Phthalate suppresses estradiol and ovulation in cycling rats.  Toxicol Appl Pharmacol. 1994;  128 216-223
• 53 Perry MJ, Ouyang F, Korrick SA, Venners SA, Chen C, Xu X, Lasley BL, Wang X. Prospective study of serum DDT and progesterone and estrogen levels across the menstrual cycle in nulliparous women of reproductive age.  Am J Epidemiol. 2006;  164 1056-1064
• 54 Hutz RJ, Carvan MJ, Baldridge MG, Conley LK, Heiden TK. Environmental toxicants and effects on female reproductive function.  Tren Reprod Bio. 2006;  2 1-11
• 55 Gerhard I, Frick A, Monga B, Runnebaum B. Pentachlorophenol exposure in women with gynecological and endocrine dysfunction.  Environ Res. 1999;  80 383-388
• 56 Takeuchi T, Tsutsumi O, Ikezuki Y, Takai Y, Taketani Y. Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction.  Endocr J. 2004;  51 165-169
• 57 Rier SE. The potential role of exposure to environmental toxicants in the pathophysiology of endometriosis.  Ann N Y Acad Sci. 2002;  955 201-212
• 58 Yang Z, Agarwal SK, Foster WG. Subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin modulates the pathophysiology of endometriosis in the cynomolgus monkey.  Toxicol Sci. 2000;  56 374-381
• 59 Reddy BS, Rozati R, Reddy BV, Raman NV. Association of phthalate esters with endometriosis in Indian women.  BJOG. 2006;  113 515-520
• 60 Cobellis L, Latini G, DeFelice C, Razzi S, Paris I, Ruggieri F, Mazzeo P, Petraglia F. High plasma concentrations of di-(2-ethylhexyl)-phthalate in women with endometriosis.  Hum Reprod. 2003;  18 1512-1515
• 61 Jenkins S, Rowell C, Wang J, Lamartiniere CA. Prenatal TCDD exposure predisposes for mammary cancer in rats.  Reprod Toxicol. 2007;  23 391-396
• 62 Ibarluzea JM, Fernandez MF, Santa-Marina L, Olea-Serrano MF, Rivas AM, Aurrekoetxea JJ. Breast cancer risk and the combined effect of environmental estrogens.  Cancer Causes Control. 2004;  15 591-600
• 63 Woodruff TJ, Carlson AC, Schwartz JM, Giudice LG. Proceedings of the Summit on Environmental Challenges to Reproductive Health and Fertility: executive summary.  Fertil Steril. 2008;  89 1-20
• 64 Howdeshell KL. A model of the development of the brain as a construct of the thyroid system.  Environ Health Perspect. 2002;  110 337-348
• 65 Zoeller RT. Environmental chemicals impacting the thyroid: targets and consequences.  Thyroid. 2007;  17 811-817
• 66 Boas M, Feldt-Rasmussen U, Skakkebæk NE, Main KM. Environmental chemicals and thyroid function.  Eur J Endocrinol. 2006;  154 599-611
• 67 Hagmar L, Bjork J, Sjodin A, Bergman A, Erfurth EM. Plasma levels of persistent organohalogens and hormone levels in adult male humans.  Arch Environ Health. 2001;  56 138-143
• 68 Langer P, Koban A, Tajtakova M, Koška J, Radikova Z, Kšinantova L, Imrich R, Hucková M, Drobná B, Gasperíková D, Seböková E, Klimes I. Increased thyroid volume, prevalence of thyroid antibodies and impaired fastingand impaired fasting glucose in young adults from organochlorine cocktail polluted area: Outcome of transgenerational transmission?.  Chemosphere. 2008;  73 1145-1150
• 69 Ribas-Fitó N, Sala M, Kogevinas M, Sunyer J. Polychlorinated biphenyls (PCBs) and neurological development in children: a systematic review.  J Epidemiol Community Health. 2001;  55 537-546
• 70 Koopman-Esseboom C, Morse DC, Weisglas-Kup E, Lutkeschipholt IJ, Van der Paauw CG, Tuinstra LG, Brouwer A, Sauer PJ. Effects of dioxins and polychlorinated biphenyls on thyroid hormone status of pregnant women and their infants.  Pediatr Res. 1994;  36 468-473
• 71 Baillie-Hamilton PF. Chemical toxins: a hypothesis to explain the global obesity epidemic.  J Altern Complement Med. 2002;  8 185-192
• 72 Kanayama T, Kobayashi N, Mamiya S, Nakanishi T, Nishikawa J. Organotin compounds promote adipocyte differentiation as agonists of the peroxisome proliferator-activated receptor-γ/retinoid X receptor pathway.  Mol Pharmacol. 2005;  67 766-774
• 73 Grün F, Watanabe H, Zamanian Z, Maeda L, Arima K, Cubacha R, Gardiner DM, Kanno J, Iguchi T, Blumberg B. Endocrine-disrupting organotin compounds are potent inducers of adipogenesis in vertebrates.  Mol Endocrinol. 2006;  20 2141-2155
• 74 Stahlhut RW, van Wijngaarden E, Dye TD, Cook S, Swan SH. Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males.  Environ Health Perspect. 2007;  115 876-882
• 75 Hatch EE, Nelson JW, Qureshi MM, Weinberg J, Moore LL, Singer M, Webster TF. Association of urinary phthalate metabolite concentrations with body mass index and waist circumference: a cross-sectional study of NHANES data, 1999–2002.  Environmental Health. 2008;  7 27
• 76 Masuno H, Kidani T, Sekiya K, Sakayama K, Shiosaka T, Yamamoto H, Honda K. Bisphenol A in combination with insulin can accelerate the conversion of 3T3-L1 fibroblasts to adipocytes.  J Lipid Res. 2002;  43 676-684
• 77 Szkudelska K, Nogowski L, Szkudelski T. Genistein affects lipogenesis and lipolysis in isolated rat adipocytes.  J Steroid Biochem Mol Biol. 2000;  75 265-271
• 78 Wada K, Sakamoto H, Nishikawa K, Sakuma S, Nakajima A, Fujimoto Y, Kamisaki Y. Life style-related diseases of the digestive system: Endocrine disruptors stimulate lipid accumulation in target cells related to metabolic syndrome.  J Pharmacol Sci. 2007;  105 133-137
• 79 Newbold RR, Padilla-Banks E, Snyder RJ, Jefferson WN. Perinatal exposure to environmental estrogens and the development of obesity.  Mol Nutr Food Res. 2007;  51 912-917
• 80 Newbold RR, Padilla-Banks E, Jefferson WN, Heinde JJ. Effects of endocrine disruptors on obesity.  Int J Androl. 2008;  31 201-208
• 81 Rubin ÂBS, Murray MK, Damassa DA, King JC, Soto AM. Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels.  Environ Health Perspect. 2001;  109 675-680
• 82 Hoppe AA, Carey GB. Polybrominated diphenyl ethers as endocrine disruptors of adipocyte metabolism.  Obesity (Silver Spring). 2007;  15 2942-2950
• 83 Sakurai K, Kawazuma M, Adachi T, Harigaya T, Saito Y, Hashimoto N, Mori C. Bisphenol A affects glucose transport in mouse 3T3-F442A adipocytes.  Br J Pharmacol. 2004;  141 209-214
• 84 Hugo ER, Brandebourg TD, Woo JG, Loftus J, Alexander JW, Ben-Jonathan N. Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes.  Environ Health Perspect. 2008;  116 1642-1647
• 85 Boberg J, Metzdorff S, Wortzigera R, Axelstada M, Brokkenb L, Vinggaarda AM, Dalgaarda M, Nellemann C. Impact of diisobutyl phthalate and other PPAR agonists on steroidogenesis and plasma insulin and leptin levels in fetal rats.  Toxicology. 2008;  250 75-81
• 86 Naaz A, Yellayi S, Zakroczymski MA, Bunick D, Doerge DR, Lubahn DB, Helferich WG, Cooke PS. The Soy isoflavone genistein decreases adipose deposition in mice.  Endocrinology. 2003;  144 3315-3320
• 87 Penza M, Montani C, Romanii A, Vignolini P, Pampaloni B, Tanini A, Brandi ML, Alonso-Magdalena P, Nadal A, Ottobrini L, Parolini O, Bignotti E, Calza S, Maggi A, Grigolato PG, Di Lorenzo D. Genistein affects adipose tissue deposition in a dose-dependent and gender-specific manner.  Endocrinology. 2006;  147 5740-5751
• 88 Parker VG, Mayo RM, Logan BN, Holder BJ, Smart PT. Toxins and diabetes mellitus: An environmental connection?.  Diabetes Spectrum. 2002;  15 109-112
• 89 vom Saal FS, Myers JP. Bisphenol A and risk of metabolic disorders.  JAMA. 2008;  300 1353-1355
• 90 Pesatori AC, Zocchetti C, Guercilena S, Consonni D, Turrini D, Bertazzi PA. Dioxin exposure and non-malignant health effects: a mortality study.  Occup Environ Med. 1998;  55 126-131
• 91 Bertazzi PA, Consonni D, Bachetti S, Rubagotti M, Baccarelli A, Zocchetti C, Pesatori AC. Health effects of dioxin exposure: A 20-year mortality study.  Am J Epidemiol. 2001;  153 1031-1044
• 92 Henriksen GL, Ketchum NS, Michalek JE, Swaby JA. Serum dioxin and diabetes mellitus in veterans of Operation Ranch Hand.  Epidemiology. 1997;  8 252-258
• 93 Steenland K, Piacitelli L, Deddens J, Fingerhut M, Chang LI. Cancer, heart disease, and diabetes in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.  J Natl Cancer Inst. 1999;  91 779-786
• 94 Zober A, Ott MG, Messerer P. Morbidity follow up study of BASF employees exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) after a 1953 chemical reactor incident.  Occup Environ Med. 1994;  51 479-486
• 95 Lai MS, Hsueh YM, Chen CJ, Shyu MP, Chen SY, Kuo TL, Wu MM, Tai TY. Ingested inorganic arsenic and prevalence of diabetes mellitus.  Am J Epidemiol. 1994;  139 484-492
• 96 Meliker JR, Wahl RL, Cameron LL, Nriagu JO. Arsenic in drinking water and cerebrovascular disease, diabetes mellitus, and kidney disease in Michigan: a standardized mortality ratio analysis.  Environmental Health. 2007;  6 4
• 97 Lang IA, Galloway TS, Scarlett A, Henley WA, Depledge M, Wallace RB, Melzer D. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults.  JAMA. 2008;  300 1303-1310
• 98 Quesada I, Fuentes E, Viso-leon MC, Soria B, Ripoll C, Nadal A. Low doses of the endocrine disruptor bisphenol-A and the native hormone 17β-estradiol rapidly activate transcription factor CREB1.  FASEB J. 2002;  16 1671-1673
• 99 Alonso-Magdalena P, Morimoto S, Ripoll C, Fuentes E, Nadal A. The estrogenic effect of bisphenol-A disrupts pancreatic β-cell function in vivo and induces insulin resistance.  Environ Health Perspect. 2006;  114 106-112
• 100 Alonso-Magdalena P, Laribi O, Ropero AB, Fuentes E, Ripoll C, Soria B, Nadal A. Low doses of bisphenol A and diethylstilbestrol impair Ca2+ signals in pancreatic α-cells through a nonclassical membrane estrogen receptor within intact islets of Langerhans.  Environ Health Perspect. 2005;  113 969-977

Correspondence